Biomarin Pharmaceutical (BMRN) Change in Intangibles (2017 - 2025)
Biomarin Pharmaceutical (BMRN) reported Change in Intangibles of $2.37 million for Q4 2025, up 207.9% from $769,000 a year earlier but down 55.3% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Change in Intangibles (2017 - 2025) Analysis & Trends
For FY2025, Biomarin Pharmaceutical posted Change in Intangibles of $7.94 million, down 33.8% from FY2024.
- Change in Intangibles has a five-year compound annual growth rate of -19.3% (FY2020 to FY2025).
- By year, Change in Intangibles came in at $11.99 million in FY2024 (+9.8%), $10.92 million in FY2023 (+3.2%), $10.58 million in FY2022 (-55.3%) and $23.65 million in FY2021 (+1.9%).
- Five-year quarterly Change in Intangibles spans a low of $266,000 in Q2 2025 and a high of $15.62 million in Q4 2021.
- Year over year, Change in Intangibles gained in three of the last six quarters, with growth averaging 28.5%.
- The high point for year-over-year Change in Intangibles in five years was Q3 2022 (growth of 341.0%); the low point was Q4 2022 (a decline of 95.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Intangibless (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.28 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -437.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.34 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 266,000.00 |
| Dec 31, 2024 | 769,000.00 |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 512,000.00 |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 7.78 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 310,000.00 |
| Dec 31, 2022 | 671,000.00 |
| Sep 30, 2022 | 7.17 Mn |
| Jun 30, 2022 | 881,000.00 |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 15.62 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 3.65 Mn |
| Mar 31, 2021 | 2.75 Mn |
| Dec 31, 2020 | 8.84 Mn |
API Access
Biomarin Pharmaceutical Change in Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-intangibles", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();